This article presents a collection of biotech funding announcements, indicating a continued investment in the development of novel treatments across various therapeutic areas. Notably, Rakuten Medical's focus on recurrent head and neck cancer reflects growing efforts to address this challenging condition through combination therapies. Corsera Health's preventative RNAi medicines for cardiovascular health demonstrate an innovative approach to addressing a significant public health concern. Finall...